"Gilead Sciences Inc. (NASDAQ:GILD) is believed by RBC Capital as being the best growth outlook among large cap companies, and the firm predicts that the company will report positive data on its HCV treatment during the next month. The firm keeps its Outperform rating on the stock." --------------- Get ready for more upside on the stock. My take.....high $80s.PHOINIX20The Eternal Bird
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst R